Training and organizational development to health products regulatory authority
The backbone of local vaccine production is an effective national regulatory authority to ensure the quality and safety of vaccines. GIZ, through its Vaccines for Africa: Roll-out and Production in South Africa" (SAVax) project, is supporting the South African Health Products Regulatory Authority (SAHPRA) to make its operations more effective and efficient. SAHPRAs goal is for South Africa to become the first African country (so far) to achieve WHO Maturity Level 4 for both vaccine and drug regulation by 2025. SAHPRA also has the ambition to increase its role in supporting regional and continental regulatory harmonization. Finally, in August 2023, SAHPRA was designated by AUDA-NEPAD as a Regional Center of Regulatory Excellence (RCORE) for Vaccines Regulatory Oversight for a period of four years in 9 key functions.
GFAs technical assistance to SAHPRA under the GIZ SAVax project is focused on two packages of activities: Training for key regulatory processes and support for organizational development. The activities will be carried out in close cooperation with the GIZ project in Pretoria and the partner SAHPRA.
